UFKA-20

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameUFKA-20
Drug Alias NameUFKA-20
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-2 stimulants
TargetsInterleukin-2
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Zurich
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Zurich
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A